drugset / Trial / NCT05192213

Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock

NCT05192213

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A great interest exists regarding substances with an immunomodulatory effect for sepsis patients. Recent data have shown that intravenous vitamin C, together with corticosteroids and thiamine, could prevent progressive organ dysfunction and reduce vasopressor use in patients with severe sepsis and septic shock. Its effect on mortality, on the other hand, is yet to be demonstrated. The Vitamins study aims to conclusively determine, through its prospective, multicentre and double-blinded design including 1090 patients, wether Vitamin C, Thiamine and Hydrocortisone in combination can reduce mortality in patients with septic shock.

Timeline

Start
2021-08-01
Primary completion
2022-07-14
Completion
2022-09-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiamine Other / unclassified 200 mg
Subject Vitamin C Other / unclassified 1.5 g Intravenous
Background Hydrocortisone Other / unclassified 50 mg